Transaction|April 8, 2015
Concordia Healthcare closes C$368 million bought deal financing
Torys acted as counsel to the syndicate of underwriters led by RBC Capital Markets with a team that included Cheryl Reicin, Eric Foster, Miranda Callaghan and Jonah Goldberg (Canadian securities), Andy Beck and Erin Wiley (U.S. securities) and Andrew Wong (tax).
On April 8, 2015, Concordia Healthcare Corp. (Concordia) closed its previously announced short form prospectus offering of 4,329,428 subscription receipts, including the exercise by the underwriters of an over-allotment option of 15%, for aggregate gross proceeds of C$368,001,380. The offering was completed, on a bought deal basis, at a price per subscription receipt of C$85.00 by a syndicate of underwriters led by RBC Capital Markets, as sole bookrunner and co-lead manager, and including GMP Securities L.P. as co-lead manager and TD Securities Inc.
Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs.
Further information can be found on Stockhouse's website.